FDA approves breakthrough hepatitis C drug

Your Health Matters

WASHINGTON (AP) — Federal health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave